Ardythe L Morrow, PhD, Director, Center for Interdisciplinary Research in Human Milk and Lactation at the Cincinnati Children's Hospital Medical Center, discusses human milk oligosaccharides (HMO) as an essential, bioactive component of breast milk. Dr. Morrow reviews the proposed advantages of HMO, and addresses the need for additional clinical trial testing to fully define the benefit of HMO-supplementation.